✦ LIBER ✦

Prognostic factors in metastatic melanoma

✍ Scribed by Louise Ryan; Andrew Kramar; Ernest Borden

Publisher: John Wiley and Sons
Year: 1993
Tongue: English
Weight: 796 KB
Volume: 71
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19930515)71:10<2995::aid-cncr2820711018>3.0.co;2-p

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Prognostic factors in patients with meta

Prognostic factors in patients with metastatic malignant melanoma: A multivariate analysis

✍ Matthew N. Sirott; Dean F. Bajorin; George Y. C. Wong; Yue Tao; Paul B. Chapman; 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 780 KB

Prognostic factors in metastatic maligna

Prognostic factors in metastatic malignant melanoma. The southeastern cancer study group experience

✍ Gary A. Presant; Alfred A. Bartolucci 📂 Article 📅 1982 🏛 John Wiley and Sons 🌐 English ⚖ 375 KB 👁 2 views

Elevated serum level of YKL-40 is an ind

Elevated serum level of YKL-40 is an independent prognostic factor for poor survival in patients with metastatic melanoma

✍ Henrik Schmidt; Julia Sidenius Johansen; Julie Gehl; Poul F. Geertsen; Kirsten F 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 255 KB 👁 2 views

Erratum: Schmidt H, Johansen JS, Gehl J,

Erratum: Schmidt H, Johansen JS, Gehl J, et al. Elevated serum level of YKL-40 is an independent prognostic factor for poor survival in patients with metastatic melanoma. Cancer. 2006;106(5):1130–9.

📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB 👁 2 views

Prognostic factors in metastatic prostat

Prognostic factors in metastatic prostate cancer

✍ H. Matzkin; P. E. Perito; M. S. Soloway 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 580 KB

Prognostic factors in thin cutaneous mal

Prognostic factors in thin cutaneous malignant melanoma

✍ Eva Månsson-Brahme; John Carstensen; Kerstin Erhardt; Bengt Lagerlöf; Ulrik Ring 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 805 KB

Background. Thin melanomas can metastasize and be lethal. The predictive importance of tumor thickness in thin melanomas and the specific features identifying the patients at risk have not been investigated fully. Methods. Prognostic factors were analyzed in 585 patients with clinical Stage I invas